07.01.14
Researchers at Wayne State University have conducted preliminary research that suggests grape skin extract (GSE) may yield an inhibitory effect on hyperglycemia. This research could be used to manage diabetes, which currently affects approximately 26 million people in the U.S.
Funded by the National Center for Complementary and Alternative Medicine of the National Institutes of Health, this $2.1 million transitional study aimed to provide insights into the novel inhibitory action of GSE on postprandial hyperglycemia and provides preclinical data in support of the biological effectiveness and safety of GSE and its components in potential prevention and treatment of type 2 diabetes.
“It is hopeful that our research may eventually lead to the successful development of a safe, targeted nutritional intervention to support diabetes prevention and treatment,” said Kequan Zhou, PhD, assistant professor of food and nutrition science in the College of Liberal Arts and Sciences, and lead investigator on the grant. “Our study will provide important pre-clinical data regarding the anti-diabetic mechanisms, biological efficacy and safety of GSE that should facilitate eventual translation into future clinical studies to assess GSE and its components as a safe, low-cost and evidence-based nutritional intervention for diabetes.”
Funded by the National Center for Complementary and Alternative Medicine of the National Institutes of Health, this $2.1 million transitional study aimed to provide insights into the novel inhibitory action of GSE on postprandial hyperglycemia and provides preclinical data in support of the biological effectiveness and safety of GSE and its components in potential prevention and treatment of type 2 diabetes.
“It is hopeful that our research may eventually lead to the successful development of a safe, targeted nutritional intervention to support diabetes prevention and treatment,” said Kequan Zhou, PhD, assistant professor of food and nutrition science in the College of Liberal Arts and Sciences, and lead investigator on the grant. “Our study will provide important pre-clinical data regarding the anti-diabetic mechanisms, biological efficacy and safety of GSE that should facilitate eventual translation into future clinical studies to assess GSE and its components as a safe, low-cost and evidence-based nutritional intervention for diabetes.”